Pharmacology for GAD: Complex Choices
The Carlat Psychiatry Report, Volume 17, Number 11&12, November 2019
Randall Moore, MD.
Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
A meta-analysis of 25 medications in over 25,000 patients with generalized anxiety disorder. The usual FDA-approved options are there, along with some surprises. Not all are equal, but the most effective of the bunch carries so many side effects that we can only recommend it as a last resort.